Skip to content

QL Block in Laparoscopic Myomectomy

Quadratus Lumborum Block to Improve Postoperative Pain Management After Laparoscopic Myomectomies: a Double-blinded and Prospective Randomized Clinical Trial.

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05979493
Enrollment
80
Registered
2023-08-07
Start date
2024-08-24
Completion date
2028-07-03
Last updated
2026-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fibroid Uterus, Postoperative Pain

Keywords

QL Block, Myomectomy

Brief summary

This study aims to determine the efficacy of a quadratus lumborum (QL) block in decreasing postoperative pain in patients undergoing myomectomy for uterine fibroids. A QL block is a temporary anesthetic injection in the quadratus lumborum muscle, a muscle in the lower back, that has been previously shown to significantly reduce postoperative pain levels in patients undergoing abdominal and pelvic surgery. Because of its demonstrated effects, the QL block is becoming a standard of anesthesia and surgical care. Since participants will be undergoing a myomectomy procedure, the investigators believe that participants may qualify to participate in this study. The investigators will be comparing patients who receive the QL block (in addition to standard anesthesia and postoperative pain care) with patients who do not receive the QL block (in addition to standard care). The participants will be randomly assigned to one of the two groups and may or may not actually receive the block.

Interventions

DRUGBupivacain

30cc IM injection in each quadratus lumborum muscle (60cc total).

DRUGSaline

30cc IM injection in each quadratus lumborum muscle (60cc total).

Sponsors

Joseph Findley MD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

* Presence of uterine fibroids requiring surgical excision with preservation of the uterus * Stated willingness to comply with all study procedures and availability for the duration of the study * Provision of signed and dated informed consent form

Exclusion criteria

* Pre-existing diagnoses of anxiety or depression * Pre-existing coagulopathies * Pre-existing neuropathic or chronic pelvic pain * Chronic opioid use * Illiteracy due to inability to read and understand plain questionnaire * Non-English speaking * BMI \>38

Design outcomes

Primary

MeasureTime frame
Time in minutes from first analgesic request as measured by medical chart reviewUp to 24 hours
Total number of doses of rescue analgesics given as measured by medical chart reviewUp to 24 hours

Secondary

MeasureTime frameDescription
Pain as measured by visual analog scale (VAS)Up to 48 hours after discharge from hospital.VAS is a pain scale from 0-10 with 0 being no pain and 10 being the worst pain ever.
Patient satisfaction with perioperative pain management measured on a scale of 1-10Up to 48 hours after discharge from hospital.Pain management scale with 1 being very disappointed in pain management with 10 being highly satisfied with pain managment.

Countries

United States

Contacts

CONTACTCatherine P Haering, BA
cph43@case.edu3392011531
PRINCIPAL_INVESTIGATORJoseph Findley, MD

University Hospitals

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 12, 2026